These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12705692)

  • 1. Insulin assays: previously known and new analytical features.
    Sapin R
    Clin Lab; 2003; 49(3-4):113-21. PubMed ID: 12705692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-insulin antibodies in insulin immunometric assays: a still possible pitfall.
    Sapin R
    Eur J Clin Chem Clin Biochem; 1997 May; 35(5):365-7. PubMed ID: 9189740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive study of human insulin immunoassays: promises and pitfalls for insulin analogue detection and quantification.
    Heurtault B; Reix N; Meyer N; Gasser F; Wendling MJ; Ratomponirina C; Jeandidier N; Sapin R; Agin A
    Clin Chem Lab Med; 2014 Mar; 52(3):355-62. PubMed ID: 24150210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactivity of insulin analogues with three insulin assays.
    Dayaldasani A; Rodríguez Espinosa M; Ocón Sánchez P; Pérez Valero V
    Ann Clin Biochem; 2015 May; 52(Pt 3):312-8. PubMed ID: 25172526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of insulin immunoassays in clinical studies involving rapid-acting insulin analogues: Bi-insulin IRMA preliminary assessment.
    Agin A; Jeandidier N; Gasser F; Grucker D; Sapin R
    Clin Chem Lab Med; 2006; 44(11):1379-82. PubMed ID: 17087654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.
    Pfützner A; Kann PH; Pfützner AH; Kunt T; Larbig M; Weber MM; Forst T
    Clin Lab; 2004; 50(9-10):567-73. PubMed ID: 15481632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of immunochemiluminometric assays for the measurement of insulin and C-peptide using the ADVIA Centaur.
    El Kenz H; Bergmann P
    Clin Lab; 2004; 50(3-4):171-4. PubMed ID: 15074471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
    Bolli GB
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High fasting serum insulin level due to autoantibody interference in insulin immunoassay discloses autoimmune insulin syndrome: a case report.
    Lamy PJ; Sault C; Renard E
    Ann Biol Clin (Paris); 2016 Aug; 74(4):490-4. PubMed ID: 27492703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of anti-insulin antibodies and cross-reactivity with human recombinant insulin analogues in the E170 insulin immunometric assay.
    Kim S; Yun YM; Hur M; Moon HW; Kim JQ
    Korean J Lab Med; 2011 Jan; 31(1):22-9. PubMed ID: 21239867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin analogues in the management of diabetes.
    Vázquez-Carrera M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2004; 26(6):445-61. PubMed ID: 15349139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-chip integration of enzyme and immunoassays: simultaneous measurements of insulin and glucose.
    Wang J; Ibáñez A; Chatrathi MP
    J Am Chem Soc; 2003 Jul; 125(28):8444-5. PubMed ID: 12848544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program.
    Achenbach P; Schlosser M; Williams AJ; Yu L; Mueller PW; Bingley PJ; Bonifacio E
    Clin Immunol; 2007 Jan; 122(1):85-90. PubMed ID: 17059894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glargine blood biotransformation: in vitro appraisal with human insulin immunoassay.
    Agin A; Jeandidier N; Gasser F; Grucker D; Sapin R
    Diabetes Metab; 2007 Jun; 33(3):205-12. PubMed ID: 17360218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory evaluation of a new specific ELISA for intact proinsulin.
    Pfützner A; Pfützner AH; Kann PH; Stute R; Löbig M; Yang JW; Mistry J; Forst T
    Clin Lab; 2005; 51(5-6):243-9. PubMed ID: 15991797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.
    Rolla AR; Rakel RE
    Clin Ther; 2005 Aug; 27(8):1113-25. PubMed ID: 16199240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy.
    Yokoyama H; Tada J; Kamikawa F; Kanno S; Yokota Y; Kuramitsu M
    Diabetes Res Clin Pract; 2006 Jul; 73(1):35-40. PubMed ID: 16513202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interference of insulin antibodies in insulin immunometric assays.
    Sapin R
    Clin Chem Lab Med; 2002 Jul; 40(7):705-8. PubMed ID: 12241018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin immunoassays in the detection of insulin analogues in factitious hypoglycemia.
    Neal JM; Han W
    Endocr Pract; 2008 Nov; 14(8):1006-10. PubMed ID: 19095600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.